A systematic review of qualitative evidence on factors enabling and deterring uptake of HIV self-testing in Africa.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
15 Oct 2019
Historique:
received: 08 05 2019
accepted: 25 09 2019
entrez: 17 10 2019
pubmed: 17 10 2019
medline: 19 12 2019
Statut: epublish

Résumé

More than 40% of adults in Sub-Saharan Africa are unaware of their HIV status. HIV self-testing (HIVST) is a novel approach with a potential to increase uptake of HIV testing and linkage to care for people who test HIV positive. We explored HIV stakeholder's perceptions about factors that enable or deter the uptake of HIV self-testing and experiences of self-testing of adult users in Africa. This systematic review of qualitative evidence included articles on qualitative studies published or made available between January 1998 to February 2018 on perspectives of key stakeholders, including HIV policymakers, HIV experts, health care providers, and adult men and women (18 years and above) about factors that enable or deter the uptake of HIV self-testing and experiences of self-testing among adult users. We searched CINAHL, MEDLINE in Pubmed, EMBASE, AJOL, PsycINFO, Social Science Citation Index (SSCI), and Web of Science for articles in English on HIVST with qualitative data from different African countries. In total, 258 papers were retrieved, and only nine (9) studies conducted in 5 African countries were eligible and included in this synthesis. Perceived facilitators of the uptake of HIVST were autonomy and self-empowerment, privacy, confidentiality, convenience, opportunity to test, including couples HIV testing, and ease of use. The perceived barriers included the cost of buying self-test kits, perceived unreliability of test results, low literacy, fear and anxiety of a positive test result, and potential psychological and social harms. HIV stakeholder's concerns about HIVST included human right issues, lack of linkage to care, lack of face-to-face counseling, lack of regulatory and quality assurance systems, and quality of self-test kits. Actual HIVST users expressed preference of oral-fluid self-testing because of ease of use, and that it is less invasive and painless compared to finger-stick/whole blood-based HIV tests. Lack of clear instructions on how to use self-test kits, and existing different products of HIVST increases rates of user errors. Overcoming factors that may deter HIV testing, and HIVST, in particular, is complex and challenging, but it has important implications for HIV stakeholders, HIVST users, and public health in general. Research is warranted to explore the actual practices related to HIVST among different populations in Africa.

Sections du résumé

BACKGROUND BACKGROUND
More than 40% of adults in Sub-Saharan Africa are unaware of their HIV status. HIV self-testing (HIVST) is a novel approach with a potential to increase uptake of HIV testing and linkage to care for people who test HIV positive. We explored HIV stakeholder's perceptions about factors that enable or deter the uptake of HIV self-testing and experiences of self-testing of adult users in Africa.
METHODS METHODS
This systematic review of qualitative evidence included articles on qualitative studies published or made available between January 1998 to February 2018 on perspectives of key stakeholders, including HIV policymakers, HIV experts, health care providers, and adult men and women (18 years and above) about factors that enable or deter the uptake of HIV self-testing and experiences of self-testing among adult users. We searched CINAHL, MEDLINE in Pubmed, EMBASE, AJOL, PsycINFO, Social Science Citation Index (SSCI), and Web of Science for articles in English on HIVST with qualitative data from different African countries.
RESULTS RESULTS
In total, 258 papers were retrieved, and only nine (9) studies conducted in 5 African countries were eligible and included in this synthesis. Perceived facilitators of the uptake of HIVST were autonomy and self-empowerment, privacy, confidentiality, convenience, opportunity to test, including couples HIV testing, and ease of use. The perceived barriers included the cost of buying self-test kits, perceived unreliability of test results, low literacy, fear and anxiety of a positive test result, and potential psychological and social harms. HIV stakeholder's concerns about HIVST included human right issues, lack of linkage to care, lack of face-to-face counseling, lack of regulatory and quality assurance systems, and quality of self-test kits. Actual HIVST users expressed preference of oral-fluid self-testing because of ease of use, and that it is less invasive and painless compared to finger-stick/whole blood-based HIV tests. Lack of clear instructions on how to use self-test kits, and existing different products of HIVST increases rates of user errors.
CONCLUSIONS CONCLUSIONS
Overcoming factors that may deter HIV testing, and HIVST, in particular, is complex and challenging, but it has important implications for HIV stakeholders, HIVST users, and public health in general. Research is warranted to explore the actual practices related to HIVST among different populations in Africa.

Identifiants

pubmed: 31615461
doi: 10.1186/s12889-019-7685-1
pii: 10.1186/s12889-019-7685-1
pmc: PMC6794839
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1289

Références

Implement Sci. 2018 Jan 25;13(Suppl 1):4
pubmed: 29384080
AIDS Behav. 2014 Jul;18 Suppl 4:S396-404
pubmed: 24929834
AIDS. 2017 Jul 1;31 Suppl 3:S203-S212
pubmed: 28665878
J Health Serv Res Policy. 2002 Oct;7(4):209-15
pubmed: 12425780
AIDS Behav. 2016 Apr;20(4):870-9
pubmed: 26438487
J Int AIDS Soc. 2019 Mar;22 Suppl 1:e25256
pubmed: 30912306
BMC Med Res Methodol. 2012 Nov 27;12:181
pubmed: 23185978
Implement Sci. 2018 Jan 25;13(Suppl 1):9
pubmed: 29384078
AIDS Behav. 2018 Feb;22(2):560-568
pubmed: 28699017
Ann Emerg Med. 2011 Jul;58(1 Suppl 1):S74-8
pubmed: 21684413
AIDS Behav. 2014 Jul;18 Suppl 4:S391-5
pubmed: 24986599
BMC Int Health Hum Rights. 2018 Jan 18;18(1):5
pubmed: 29347929
J Int AIDS Soc. 2017 Aug 29;20(Suppl 6):22190
pubmed: 28872270
Implement Sci. 2018 Jan 25;13(Suppl 1):13
pubmed: 29384081
PLoS Med. 2013;10(4):e1001414
pubmed: 23565066
Implement Sci. 2018 Jan 25;13(Suppl 1):14
pubmed: 29384077
BMJ Open. 2018 Nov 8;8(11):e022652
pubmed: 30413504
AIDS Behav. 2014 Jul;18 Suppl 4:S433-7
pubmed: 24938364
PLoS Med. 2011 Oct;8(10):e1001102
pubmed: 21990966
BMC Med Res Methodol. 2008 Jul 10;8:45
pubmed: 18616818
AIDS Behav. 2014 Jul;18 Suppl 4:S422-32
pubmed: 24947852
AIDS Behav. 2015 Nov;19(11):1949-65
pubmed: 26054390
Implement Sci. 2018 Jan 25;13(Suppl 1):2
pubmed: 29384079
AIDS Behav. 2014 Jul;18 Suppl 4:S438-44
pubmed: 24974124
Clin Infect Dis. 2013 Jul;57(1):126-38
pubmed: 23487385
PLoS One. 2018 Jan 10;13(1):e0189475
pubmed: 29320504
Pan Afr Med J. 2013 Jun 09;15:50
pubmed: 24106578
PLoS Med. 2015 Oct 27;12(10):e1001895
pubmed: 26506244
Soc Sci Med. 2003 Feb;56(4):671-84
pubmed: 12560003
BMC Med. 2016 Feb 19;14:34
pubmed: 26891969
PLoS Med. 2013 Aug;10(8):e1001496
pubmed: 23966838
PLoS One. 2018 Nov 14;13(11):e0207263
pubmed: 30427889
J AIDS Clin Res. 2017 Aug;8(8):null
pubmed: 29051841
BMC Med Res Methodol. 2009 Aug 11;9:59
pubmed: 19671152
J Int AIDS Soc. 2017 May 15;20(1):21594
pubmed: 28530049
BMC Res Notes. 2017 Sep 18;10(1):486
pubmed: 28923121
Syst Rev. 2016 Apr 05;5:52
pubmed: 27048500
J Assoc Nurses AIDS Care. 2013 Nov-Dec;24(6):e45-56
pubmed: 23582579
AIDS Behav. 2014 Jul;18 Suppl 4:S415-21
pubmed: 24957979
J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):449-53
pubmed: 17554213
Lancet. 2012 Sep 22;380(9847):1045-6
pubmed: 23012709
PLoS One. 2012;7(9):e45168
pubmed: 23028822
J Int AIDS Soc. 2015 Mar 20;18:19445
pubmed: 25797344
PLoS One. 2013 Nov 19;8(11):e80594
pubmed: 24260432
Glob Public Health. 2015;10(3):354-65
pubmed: 25186234
PLoS One. 2015 Mar 31;10(3):e0122783
pubmed: 25826655
PLoS One. 2017 Nov 17;12(11):e0187998
pubmed: 29149194
Curr HIV/AIDS Rep. 2009 Nov;6(4):217-23
pubmed: 19849965
BMC Public Health. 2014 Aug 12;14:838
pubmed: 25124140
Sex Transm Dis. 2014 Jan;41(1):10-2
pubmed: 24326576
BMC Public Health. 2013 Aug 08;13:735
pubmed: 23924387
J Int AIDS Soc. 2017 Jun 26;20(1):21610
pubmed: 28691442
Trop Med Int Health. 2010 Jun;15 Suppl 1:16-33
pubmed: 20586957

Auteurs

Bernard Njau (B)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. biesein2007@gmail.com.
Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania. biesein2007@gmail.com.

Christopher Covin (C)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Esther Lisasi (E)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Damian Damian (D)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania.

Declare Mushi (D)

Kilimanjaro Christian Medical University College, Moshi, Kilimanjaro, Tanzania.

Andrew Boulle (A)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.

Catherine Mathews (C)

School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Health Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH